Inhibition of eNOS Partially Blunts the Beneficial Effects of Nebivolol on Angiotensin II-Induced Signaling in H9c2 Cardiomyoblasts
We have recently illustrated that nebivolol can inhibit angiotensin II (Ang II)-mediated signaling in cardiomyoblasts; however, to date, the detailed mechanism for the beneficial effects of nebivolol has not been studied. Here, we investigated whether the inhibition of NO bioavailability by blocking...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2022-05-01
|
| Col·lecció: | Current Issues in Molecular Biology |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/1467-3045/44/5/144 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|